The 323 Hospital of Chinese People's Liberation Army
Welcome,         Profile    Billing    Logout  
 12 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
WANG, Liming
NCT04709380: Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Recruiting
3
85
RoW
Radiotherapy plus Toripalimab, Sorafenib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Radiotherapy, Toripalimab, Sorafenib, Advanced Hepatocellular Carcinoma
03/24
08/24
NCT05862337: Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Recruiting
3
480
RoW
Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hepatocellular Carcinoma
08/24
12/26
NCT04791176: Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC

Active, not recruiting
2
64
RoW
concurrent lenvatinib and Radiotherapy, followed lenvatinib maintenance
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Hepatocellular Carcinoma, Radiotherapy, Lenvatinib
12/22
04/24
NCT05021250: SBRT With DIBH for HCC After TACE and Lipiodol Marking

Active, not recruiting
N/A
30
RoW
Lipiodol marking
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, The First Hospital of Jilin University, Tianjin Medical University Cancer Institute and Hospital
Hepatocellular Carcinoma
12/23
04/24
Liu, Yongjun
No trials found
Wu, Mingyuan
No trials found
Ji, Haijie
No trials found

Download Options